METHODS FOR ISOLATING ENVELOPED VIRUS-BASED VLPS FREE OF INFECTIOUS AGENTS

Chimeric HIV Antigens

METHOD OF USING TUMOR CELL DEBRIS TO REDUCE BRAIN TUMOR RECURRENCE OR GROWTH

Method for inducing a TRIF-bias

MSP-1 PROTEIN PREPARATIONS FROM PLASMODIUM

Vaccines

VACCINE COMPOSITIONS

NON-NEUTRALIZING IMMUNITY TO INFLUENZA TO PREVENT SECONDARY BACTERIAL PNEUMONIA

LIPID-COATED POLYMER PARTICLES FOR IMMUNE STIMULATION

Lipid vesicle compositions and methods of use

Compositions and methods

Vaccine

Vaccines

Vaccine compositions comprising a saponin adjuvant

Immunizing compositions and methods of use

TUBERCULOSIS RV2386C PROTEIN, COMPOSITIONS AND USES THEREOF

Immunizing compositions and methods of use

Immunizing compositions and methods of use

Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity

VACCINE AGAINST HPV

Method of conferring a protective immune response to norovirus

Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES

Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES

Novel Compositions and Adjuvants

METHODS OF TREATING AND PROTECTING AGAINST HUMAN IMMUNODEFICIENCY VIRUS

BIOACTIVE PURIFIED HSPE7 COMPOSITIONS

NOVEL USE

Immunologically active compositions

METHOD AND VACCINE FOR OPTIMIZING THE SPECIFIC IMMUNE RESPONSES

SYNERGISTIC INDUCTION OF HUMORAL AND CELLULAR IMMUNITY BY COMBINATORIAL ACTIVATION OF TOLL-LIKE RECEPTORS

Vaccine against varicella zoster virus

Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders

Parasite vaccine

Compositions and methods for preventing or treating a viral infection

Chimeric vaccine for -induced disease

Immunogenic compositions for the prevention and treatment of meningococcal disease

VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

VACCINE AGAINST VARICELLA ZOSTER VIRUS

Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidis

Multicomponent meningococcal vaccine

Therapeutic TB vaccine

VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT

Vaccine Against Streptococcus Pneumoniae

Ex vivo uses of immunostimulatory combinations

Immunogenic composition

Synthetic glucopyranosyl lipid adjuvants

Endotoxin adsorbent for the prevention and treatment of autoimmune diseases

Conjugation process for PNAG and a carrier protein

Immunoprotective influenza antigen and its use in vaccination

Detoxification method for lipopolysaccharide (LPS) or lipid A of gram-negative bacteria

Recombinant RSV antigens

Method of eliciting an immune response against pandemic influenza virus

Vaccine

METHOD FOR REFOLDING NEISSERIAL NSPA PROTEIN

VACCINE

Vaccines for malaria

VACCINES FOR MALARIA

VACCINES

METHOD OF CONFERRING A PROTECTIVE IMMUNE RESPONSE TO NOROVIRUS

Adjuvancy and immune potentiating properties of natural products of

Influenza composition

VACCINE

Adjuvant combination formulations

Methods and compositions for liposomal formulation of antigens and uses thereof

NOVEL VACCINE COMPOSITION

Immunological herpes simplex virus antigens and methods for use thereof

FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS

MAGE3 polypeptides

Process for the production of immunogenic compositions

CHIMERIC ANTIGENS

Vaccines Containing Non-Live Antigenic Vectors

Allergen formulation

Vaccines Against Chlamydial Infection

COMPOSITIONS AND METHODS FOR WT1 SPECIFIC IMMUNOTHERAPY

Compositions and methods for vaccinating against HSV-2

Compositions and methods for vaccinating against HSV-2

Compositions and methods for vaccinating against HSV-2

Immunotherapy of virus infection

Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis

Vaccine

Use of invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo

Regulation of TLR Signaling by Complement

Adjuvant comprising oligonucleotide and non-toxic lipopolysaccharide

Modified pathogens for use as vaccines

Chimeric influenza virus-like particles

NOVEL METHOD AND COMPOSITIONS

Method of inducing antibodies to human immunodeficiency virus involving the administration of MPER peptide-liposome conjugates

VACCINE COMPOSITIONS

CHIMERIC VIRUS-LIKE PARTICLES

Immunogenic Affinity-Conjugated Antigen Systems Based on Papaya Mosaic Virus and Uses Thereof

Compositions and methods for vaccinating against HSV-2

COMBINATION OF TYROSINE KINASE INHIBITOR AND HER-2/NEU FOR CANCER THERAPY

Immunogenic complexes and methods relating thereto

Use of MAGE A3-Protein D Fusion Antigen in Immunotherapy Combined with Surgery, Chemotherapy or Radiotherapy for the Treatment of Cancer

Human hookworm vaccine

Method of elicting or inducing an immune response

Adjuvant compositions

COMPOSITIONS AND METHODS FOR ACTIVATING INNATE AND ALLERGIC IMMUNITY

Nucleic Acid of Formula (I): GIXmGn, or (II): CIXmCn, in Particular as an Immune-Stimulating Agent/Adjuvant

Compositions and methods for activating innate and allergic immunity

Compositions and methods for WT1 specific immunotherapy

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

Malaria prime/boost vaccines

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES

Vaccine Compositions Comprising Virosomes and a Saponin Adjuvant

Enhancement of an immune response by administration of a cationic lipid-DNA complex (CLDC)

NOVEL PROTEOSOME-LIPOSACCHARIDE VACCINE ADJUVANT

Complexed polypeptide and adjuvant for improved vaccines

Reducing interference between oil-containing adjuvants and surfactant-containing antigens

Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture

EMULSIONS WITH FREE AQUEOUS-PHASE SURFACTANT FOR ADJUVANTING SPLIT INFLUENZA VACCINES

Prevention and treatment of amyloidogenic disease

Adjuvancy and immune potentiating properties of natural products of

VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT

VACCINE

Expressing hepatitis B virus surface antigen for vaccine preparation

MEASLES SUBUNIT VACCINE

Immunizing compositions and methods of use

Novel vaccine

VACCINE

Method for preventing or treating infection

TLR9 agonist and CD40 agonist immunostimulatory combinations

VACCINES COMPRISING OUTER MEMBRANE VESICLES FROM GRAM NEGATIVE BACTERIA

Virosome particles comprising antigens from influenza virus and hepatitis b virus

COMPOSITION

Immunizing compositions and methods of use

Bioactive molecular matrix and methods of use in the treatment of disease

Methods for Treatment and Prevention of Infection

Humanized antibodies that recognize beta amyloid peptide

Modified surface antigen

Modified surface antigen

FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS

CHANGING TH1/TH2 BALANCE IN SPLIT INFLUENZA VACCINES WITH ADJUVANTS

sterol 24-c-methyltransferase compositions for the prevention, treatment and diagnosis of leishmaniasis

Novel use

VACCINES AGAINST CHLAMYDIAL INFECTION

Advanced genetic vaccines

Emulsion vaccine compositions comprising antigen and adjuvant in the aqueous phase

Drug-delivery patch comprising a dissolvable layer and uses thereof

Anti-malaria vaccine

VIRAL VACCINE AND METHOD FOR PREPARATION THEREOF

Vaccine Composition Comprising Alpha-Galactosylceramide as an Adjuvant For Intranasal Administration

Vaccine For Periodontal Disease

Chimeric vaccine for -induced disease

Norovirus vaccine formulations

HUMANIZED ANTIBODIES THAT RECOGNIZE BETA AMYLOID PEPTIDE

Vaccine Compositions Comprising a Saponin Adjuvant

Mixture of human papillomavirus virus-like particles

T4 bacteriophage bound to a substrate

Hiv-1 Neutralizing Antibodies Elicited By Trimeric Hiv-1 Envelope Glycoprotein Complex

Modulation of NKT cell activity with antigen-loaded CD1d molecules

Prevention and treatment of amyloidogenic diseases

Prevention and treatment of amyloidogenic diseases

Compositions and methods for WT1 specific immunotherapy

Parasite vaccine

Use of penetration enhancers and barrier disruption methods to enhance the immune response of an antigen

Compositions and methods for preventing or treating a viral infection

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

Prevention and treatment of amyloidogenic disease

Composition having antitumor effect

SUBUNIT VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS INFECTION

Adjuvant systems and vaccines

Humanized antibodies that recognize beta amyloid peptide

Glycosylceramide adjuvant for saccharide antigens

NOVEL VACCINE COMPOSITION

Use Of An Influenza Virus, An Oil-In-Water Emulsion Adjuvant, To Induce Cd4 T-Cell And/Or Improved B-Memory Cell Response

Vaccine

Novel Composition

Human endogenous retrovirus polypeptide compositions and methods of use thereof

Human Hookworm Vaccine

OIL IN WATER EMULSIONS CONTAINING SAPONINS

NOVEL VACCINATION

Complexed Polypeptide and Adjuvant for Improved Vaccines

Neisseria meningitidis lgtb Los as Adjuvant

Mucinous glycoprotein (MUC-1) vaccine

Vaccine composition containing synthetic adjuvant

VACCINES

Malaria Prime/Boost Vaccines

Nanoparticle-based vaccine delivery system containing adjuvant

Novel Composition

CHLAMYDIA VACCINES

Vaccines

Compositions and methods for vaccinating against HSV-2

VACCINE COMPRISING GP120 AND NEF AND/OR TAT FOR THE IMMUNIZATION AGAINST HIV

FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS

FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS

Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection

VACCINE AGAINST STREPTOCOCCUS PNEUMONIAE

Vaccines

Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant

Endotoxin-adsorbent for the prevention and treatment of autoimmune diseases

Humanized antibodies that recognize beta amyloid peptide

Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen

Method for Refolding Neisserial Nspa Protein

Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52

Synergistic Liposomal Adjuvants

Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses

Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents

ADJUVANT IN THE FORM OF A LIPID-MODIFIED NUCLEIC ACID

Vaccines directed to cancer-associated carbohydrate antigens

Gene Construction, Vector and Dna Vaccine for the Vaccination of Aquatic Animals

Non-live trivalent influenza vaccine for one-dose intradermal delivery

Immune response stimulating composition comprising nanoparticles based on a methyl vinyl ether-maleic acid copolymer

Vaccine composition comprising virus-like particles of human papillomavirus

METHODS FOR THE PRODUCTION OF 3-O-DEACTIVATED-4'-MONOPHOSPHORYL LIPID A (3D-MLA)

Vaccine Compositions Comprising An Interleukin 18 And Saponin Adjuvant System

Anthrax antigens and methods of use

Glycolipid adjuvant compositions

COMPOSITIONS AND METHODS FOR DELIVERY OF PROTEINS AND ADJUVANTS ENCAPSULATED IN MICROSPHERES

Vaccines

1435/1449 LPS as an immune modulator

Novel plant virus particles and methods of inactivation thereof

Vaccines directed to cancer-associated carbohydrate antigens

Antibodies with simultaneous subsite specificities to protein and lipid epitopes

Influenza immunogen and vaccine

Method of making modified immunodeficiency virus particles

Inactivating pathogens with oxidizing agents for vaccine production

Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof

In vivo targeting of dendritic cells

Vaccine

Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine

Vaccine Composition Against Malaria

Vaccine compositions and methods of treating coronavirus infection

Composition

Immunogenic compositions for the prevention and treatment of meningococcal disease

Hpv-16 and-18 l1 vlp vaccine

Packaged virus-like particles

Neisserial vaccine compositions comprising a combination of antigens

Functionally reconstituted viral membranes containing adjuvant

Nanoparticle-Based vaccine delivery system containing adjuvant

Vaccines

Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents

Immune stimulating composition comprising bacterial chromosomal DNA fragments having methylated CpG sequences and non-toxic lipopolysaccharides

Methods for reducing fecal shedding

Streptococcal C5A peptidase vaccine

Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs

Composition for vaccination

Immunogenic compositions

Cross-protective epitopes of moraxella catarrhalis and use thereof

Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use

Mutant protein and refolding method

Iontophoretic device and method for administering immune response-enhancing agents and compositions

Influenza immunogen and vaccine

Vaccine comprising il-13 and an adjuvant

Vaccine

Vaccine composition against malaria

Intranasal immunization with detoxified lipooligosaccharide from nontypeable or

Novel vaccine

Vaccine composition

Methods for stimulating tlr irf3 pathways for inducing anti-microbial, anti-inflammatory and anticancer responses

Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-

Vaccine against Streptococcus pneumoniae

Compositions comprising human immunodeficiency virus Tat adsorbed to the surface of anionic nanoparticles

Adjuvancy and immune potentiating properties of natural products of

Prevention and treatment of amyloidogenic disease

Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria

Prevention and treatment of amyloidogenic disease

Intradermal delivery of vacccines and therapeutic agents

Vaccine

Vaccine

Co-encapsulated WT1 polypeptide and immunostimulant microsphere formulations and methods thereof

Prevention and treatment of amyloidogenic disease

Compositions and methods for modulating a cytotoxic T lymphocyte immune response

Prevention and treatment of amyloidogenic disease

Humanized antibodies that recognize beta amyloid peptide

Vaccine and method of use

Use of invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo

Vaccines containing a saponin and a sterol

Chylamydia vaccine

Intranasal influenza virus vaccine

Prevention and treatment of amyloidogenic disease

Prevention and treatment of amyloidogenic disease

Prevention and treatment of amyloidogenic disease

Vaccine composition comprising virus-like particles of human papillomavirus

Immune stimulating and controlling composition comprising bacterial chromosomal DNA fragments and non-toxic lipopolysaccharides

Immunological herpes simplex virus antigens and methods for use thereof

Prevention and treatment of amyloidogenic disease

Measles subunit vaccine

Prevention and treatment of amyloidogenic disease

Streptococcal C5a peptidase vaccine

Allergen formulation

Vaccine against HBV and HPV

Hepatitis A vaccines

Prevention and treatment of amyloidogenic disease

Prevention and treatment of amyloidogenic disease

Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv

Novel vaccination

Prevention and treatment of amyloidogenic disease

Prevention and treatment of amyloidogenic disease

Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant

Subunit vaccine against respiratory syncytial virus infection

Prevention and treatment of amyloidogenic disease

Fusion proteins comprising HIV-1 Tat and/or Nef proteins